Abstract
Although transfusion reactions are directly related to transfusion components, transfusion components are clinically related to the diseases afflicting patients. As some transfusion reactions can be life-threatening, estimating the incidence of transfusion reactions (which, in this study, are strictly defined as allergic and febrile non-haemolytic transfusion reactions) of certain categories of diseases is helpful for clinicians. According to the reported blood use of specific departments, the numbers of transfusion patients in these departments can be estimated. By the Association rule mining algorithm, the categories of diseases that often correlate with transfusion reactions have been screened for. It is found that the diseases belonging to C00-C97, D00-D48, D50-D89, K00-K93, N00-N99 and O00-O99 (ICD-10) often correlate with transfusion reactions. Platelet transfusion patients whose diseases belong to C00-C97 encounter transfusion reactions with an incidence of about 1%, which is much higher than the average. The incidence of transfusion reactions in patients whose diseases belong to K00-K93 –who undergo plasma transfusions –might be higher than the average, as the lower bound of this incidence is equivalent to the average incidence. Based on this study, it is suggested that attention be paid to patients whose diseases belong to C00-C97 –who undergo platelet transfusions –to prevent them from experiencing allergic transfusion reactions.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This study is not concerned with clinical study
Funding Statement
This study was supported by was supported by Fundamental Research Funds for the Central Universities (Grants:3332019170). Availability of the "Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (Grants:2018PT32016)"
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.